What Drugs Affect Vision? Common Medications & Side Effects

Explore the often-overlooked connection between prescription medications and eye health, including how to manage visual changes.

Dozens of widely prescribed medications can affect your eyesight, ranging from temporary color shifts that vanish in hours to irreversible retinal damage that develops over years. Corticosteroids, hydroxychloroquine, certain heart drugs, antihistamines, and even over-the-counter eye drops all carry documented ocular side effects. The type and severity of visual change depends heavily on the drug, the dose, and how long you take it, so the practical question is rarely a simple “does this drug affect vision?” and more often “how, how badly, and what should I watch for?”

Corticosteroids Can Cloud the Lens and Raise Eye Pressure

If one drug class deserves top billing for vision side effects, it is corticosteroids. Steroids prescribed for asthma, autoimmune conditions, skin disorders, and joint inflammation can affect the eyes in two distinct ways: by promoting cataract formation and by raising intraocular pressure toward glaucoma.

Steroid-induced cataracts typically appear as clouding at the back of the lens. The link between glucocorticoid use and these posterior subcapsular opacities has been studied for decades, and the mechanism involves oxidative stress and disruption of the lens cells’ normal ion balance. The risk is dose-dependent. In a study of children with inflammatory eye disease who received topical steroid drops, those using more than three drops per day developed cataracts at a dramatically higher rate than those using fewer drops, and this held true regardless of how active the underlying inflammation was. That finding matters because it means the steroid itself is driving the cataract, not just the disease being treated.

The pressure problem is separate. Long-term steroid use in any form, whether oral, inhaled, topical on the skin, or dropped directly into the eye, can raise intraocular pressure. If that elevated pressure goes undetected and persists, it damages the optic nerve and causes steroid-induced glaucoma, which can lead to irreversible vision loss. Not everyone who takes steroids develops elevated pressure, but certain people are more susceptible, including those with a family history of glaucoma. Regular eye-pressure checks are standard for anyone on prolonged steroid therapy.

Hydroxychloroquine and Retinal Damage

Hydroxychloroquine, commonly prescribed for lupus and rheumatoid arthritis, is one of the most closely monitored drugs in ophthalmology. Long-term use can cause retinopathy, a form of damage to the light-sensing tissue at the back of the eye that may result in severe and progressive vision loss. The damage is dose-dependent and accumulates over years, making it uncommon in the first few years of use but increasingly likely with prolonged treatment.

The tricky part is that early retinal toxicity often causes no symptoms you would notice on your own. By the time you experience blurred central vision or difficulty reading, significant damage has already occurred, and it cannot be reversed even if you stop the drug. That is why current guidelines recommend regular eye screenings, typically starting after five years of use or sooner if you take a higher daily dose relative to your body weight. In a study of lupus patients, roughly 4% of those on hydroxychloroquine developed ocular toxicity, and keeping the dose below about 5 mg per kilogram of body weight per day was found to be relatively safe for long-term use.

Medications That Change Color Vision

Two drugs are particularly well known for altering the colors you see, though they do it in completely different ways.

Sildenafil (the active ingredient in Viagra) works by blocking a specific enzyme involved in blood flow. It also weakly affects a related enzyme found exclusively in the light-sensing cells of the retina. At higher doses, this cross-reactivity can produce mild, transient visual symptoms in some users, mainly a blue tinge to vision and increased brightness of lights. Other reported effects include blurred vision, light sensitivity, and changes in how the eye responds on clinical testing. These effects are typically short-lived and resolve as the drug leaves your system, but they are real enough that pilots are advised not to fly within hours of taking the medication.

Digoxin, a heart medication derived from the foxglove plant, can cause a distinctly different color distortion. At toxic levels, it produces xanthopsia, a yellow-tinted perception of the world. The drug interferes with ion channels in retinal cells, altering the electrical signals those cells produce. This disruption selectively affects how the retina processes color information. Unlike sildenafil’s blue tinge, which is a nuisance, digoxin-induced xanthopsia is a warning sign of toxicity that warrants urgent medical attention. It has even been implicated as the cause of traffic accidents when patients did not realize they were experiencing a toxic reaction.

Antihistamines and Dry Eye

If your eyes feel gritty or scratchy while you are taking allergy medication, it is probably not your imagination. Antihistamines, particularly the older sedating type like diphenhydramine (Benadryl), reduce tear production. In a controlled study comparing diphenhydramine, loratadine, and a placebo, diphenhydramine significantly reduced tear volume, and it did so more than both the placebo and the newer-generation antihistamine.

Antihistamines are not the only culprits. Many medications with anticholinergic properties, a group that includes certain antidepressants, bladder medications, and anti-nausea drugs, can dry out the eyes by reducing secretions from the glands that produce tears. The effect tends to be worse in people who already have borderline dry eye. If you are taking one of these drugs long-term and developing dryness symptoms, preservative-free artificial tears can help, and switching to a medication with fewer anticholinergic effects may be an option worth discussing with your doctor.

Amiodarone and Corneal Deposits

Amiodarone, a powerful anti-arrhythmia drug used to treat irregular heartbeats, causes visible deposits in the cornea in nearly all patients who take it. At standard doses, roughly 98% of users develop these corneal changes, which appear as brown-to-golden whorl-shaped patterns visible during a slit-lamp exam. The deposits form because the drug disrupts the normal recycling of fats inside corneal cells, causing lipid-drug complexes to accumulate.

Despite looking dramatic under magnification, these deposits rarely cause significant visual impairment. Some patients notice mild halos or glare around lights. The deposits gradually clear after the drug is discontinued, though that process can take months. Because amiodarone is typically prescribed for potentially life-threatening heart rhythm problems, the corneal deposits are generally considered an acceptable tradeoff. Still, regular eye exams are recommended, partly because amiodarone can also, in rare cases, affect the optic nerve.

Tamsulosin and Problems During Cataract Surgery

Tamsulosin (Flomax) is one of the most commonly prescribed medications for an enlarged prostate, and it creates a problem that shows up in a setting most patients never anticipate: the operating room. During cataract surgery, the iris needs to stay dilated so the surgeon can work. In patients who take or have taken tamsulosin, the iris can become floppy, billowing and constricting unpredictably during the procedure. This is called intraoperative floppy iris syndrome, and tamsulosin is far and away its most common cause.

The condition was first described in 2005 and occurred in roughly 2% of a cataract surgery population in the initial study that characterized it. What makes it particularly vexing is that stopping tamsulosin before surgery does not reliably prevent it. The drug appears to cause lasting structural changes in the iris muscle, so the floppy behavior can persist even in patients who discontinued the medication months earlier. Experienced surgeons can manage the complication with specialized techniques, but the key is knowing about the tamsulosin history beforehand. If you have ever taken tamsulosin, mention it to any eye surgeon, even if you stopped years ago.

Topiramate and Sudden Angle Closure

Topiramate, an anti-seizure drug also prescribed for migraines and nerve pain, can trigger a sudden spike in eye pressure that mimics acute angle-closure glaucoma. The drug causes swelling in a structure behind the iris, pushing it forward and blocking the eye’s internal drainage channels. This can happen within the first few weeks of starting the medication, and it often affects both eyes simultaneously. Bilateral presentation is actually one of the red flags that the angle closure is drug-induced rather than a primary eye problem, since typical angle-closure glaucoma usually strikes one eye first.

Symptoms include sudden eye pain, blurred vision, headache, and seeing halos around lights. The treatment is stopping topiramate, not the laser or surgical procedures used for ordinary angle-closure glaucoma. Recognition is everything here: if you recently started topiramate and develop sudden eye pain, the drug should be the first suspect.

Drugs That Damage the Optic Nerve or Raise Brain Pressure

A few medications can harm vision by acting further along the visual pathway, either at the optic nerve or by raising pressure inside the skull.

Ethambutol, an antibiotic used in tuberculosis treatment, can inflame the optic nerve. Patients may lose the ability to distinguish red from green, experience blurred central vision, or develop blind spots in their visual field. The risk rises with higher doses and longer treatment courses. Because tuberculosis treatment spans months and sometimes involves ethambutol throughout, patients are typically tested for color vision and visual acuity at regular intervals. If caught early enough, vision often recovers after stopping the drug, but delayed recognition can lead to permanent loss.

A different mechanism operates with vitamin A derivatives (including the acne drug isotretinoin) and tetracycline-class antibiotics (like doxycycline and minocycline). These drugs can raise intracranial pressure, a condition that produces swelling of the optic disc visible on eye exam and symptoms like headache, pulsating ringing in the ears, and blurred or doubled vision. A systematic review identified vitamin A derivatives and tetracyclines as the drug classes most strongly linked to this complication, and the two may even have a synergistic effect when taken together. Anyone prescribed isotretinoin alongside a tetracycline antibiotic should be aware of this overlap.

Vigabatrin and Peripheral Vision Loss

Vigabatrin is an anti-seizure medication used primarily in infants with a specific type of epilepsy called infantile spasms. It is effective, but it carries a well-documented risk of damaging the retina in a way that narrows peripheral vision. The damage affects the photoreceptors responsible for detecting light at the edges of your visual field and is typically irreversible.

In children, detecting this damage is especially difficult because young patients cannot reliably perform visual field tests. A study of nearly 300 children on vigabatrin found that roughly 0.7% had definite drug-related retinal toxicity identified through specialized electrical testing of the retina, with an additional 1.4% showing optic changes of uncertain relation to the drug. Those numbers sound small, but given the severity of the vision loss when it occurs, regular monitoring with retinal testing is standard for all patients on the drug.

Fluoroquinolones and Retinal Detachment, a Debunked Scare

For years, media reports and some early observational studies raised alarm that fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, moxifloxacin) might cause retinal detachment by weakening connective tissue in the eye. The concern made biological sense on paper: fluoroquinolones affect collagen, and the vitreous gel inside the eye is largely collagen. However, the evidence has not held up.

A large cohort study from Germany found that fluoroquinolone use carried no meaningful increase in retinal detachment risk compared to other antibiotics, with an adjusted hazard ratio that was essentially 1.0. Separately, a study examining both uveitis (eye inflammation) and retinal detachment found no substantive increased risk with systemic fluoroquinolone use. While a tiny risk cannot be absolutely excluded, the current evidence indicates it would be so small as to be clinically unimportant. Fluoroquinolones have real side effects worth discussing with your doctor, but retinal detachment does not appear to be one of them.

Over-the-Counter Eye Drops That Backfire

Redness-relief eye drops sold without a prescription are among the most commonly purchased eye products, and they can create the very problem they are meant to fix. These drops work by constricting the blood vessels on the surface of the eye, and the older formulations containing naphazoline or tetrahydrozoline are particularly prone to causing rebound redness. After days, weeks, or months of regular use, the blood vessels become dependent on the drug, dilating more than they did before treatment once the drop wears off. The user then applies more drops, the cycle worsens, and eventually the eyes are chronically redder than they were at the start.

Newer formulations targeting a different receptor type have a lower risk of rebound, but the safest approach is to use any redness-relief drop sparingly and for short periods. If your eyes are persistently red, the underlying cause, whether dry eye, allergies, or something else, is more productively addressed than masked.

Visual Disturbances, Hallucinations, and Afterimages

Some drugs affect vision not at the eye itself but in the brain’s processing of visual information. Palinopsia, the perception of afterimages that linger or recur after a visual stimulus is gone, has been reported with a surprisingly varied list of medications. Prescription drugs linked to the condition include trazodone, mirtazapine, topiramate, risperidone, and clomiphene (a fertility drug). Illicit substances, with LSD being the most commonly implicated, can also trigger it. Drug-induced palinopsia tends to be of the “illusory” type, meaning the afterimages are simple visual echoes rather than vivid hallucinations. Symptoms usually begin after starting the drug or increasing the dose and resolve after discontinuation.

Targeted cancer therapies represent another expanding category. As these newer treatments see wider use, reports of ocular side effects have grown. The range of eye problems depends on the specific drug class, from dry eye and blurred vision with some agents to more serious inflammation or retinal changes with others. Patients on these regimens often already have frequent medical appointments, but a baseline eye exam before starting treatment helps establish a reference point for detecting changes.

Herbal Supplements Are Not Risk-Free

Because supplements are sold without prescriptions, many people assume they cannot affect vision. That assumption is wrong. A review of reports to the National Registry of Drug-Induced Ocular Side Effects found that several widely available supplements are associated with clinically meaningful eye problems. The list includes ginkgo biloba, echinacea, high-dose niacin (vitamin B3), high-dose vitamin A, licorice, and chamomile. The specific effects vary: canthaxanthin (a carotenoid sometimes taken as a tanning supplement) can deposit crystals in the retina, while high-dose niacin can cause a reversible swelling of the central retina that blurs vision.

The lack of mandatory adverse-event reporting for supplements means these problems are almost certainly underreported. If you are taking herbal or nutritional products and develop visual symptoms, it is worth mentioning every supplement to your eye doctor, not just your prescription medications.

How Monitoring Reduces the Risk

The sheer number of drugs that can affect vision sounds alarming, but most of these side effects are either reversible if caught in time or preventable with appropriate monitoring. The general strategy involves baseline eye exams before starting a high-risk drug, periodic follow-up screenings to catch early changes, dose adjustments when possible, and switching to an alternative medication when vision-threatening toxicity is detected.

The challenge is that prescribing doctors and eye doctors do not always communicate well. If you are starting any long-term medication, ask your prescriber directly whether it has known ocular side effects and whether eye monitoring is recommended. And when you see an eye doctor for any reason, bring a complete medication list, including over-the-counter drugs and supplements. A simple list on your phone is enough. Many of the worst outcomes from drug-related vision loss happen not because the damage was undetectable, but because nobody thought to look.